Matches in Nanopublications for { ?s ?p "[Inhibition of lp-PLA2 by darapladib leads to attenuation of in vivo inflammation and decreased plaque formation in ApoE-deficient mice, supporting an anti-atherogenic role during the progression of atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP786376.RAeR4yAjsA4dzYtiVfTJ_DqIzoZ7gKUBrdbAiI9udrYe8130_assertion description "[Inhibition of lp-PLA2 by darapladib leads to attenuation of in vivo inflammation and decreased plaque formation in ApoE-deficient mice, supporting an anti-atherogenic role during the progression of atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP786376.RAeR4yAjsA4dzYtiVfTJ_DqIzoZ7gKUBrdbAiI9udrYe8130_provenance.
- assertion description "[Inhibition of lp-PLA2 by darapladib leads to attenuation of in vivo inflammation and decreased plaque formation in ApoE-deficient mice, supporting an anti-atherogenic role during the progression of atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Inhibition of lp-PLA2 by darapladib leads to attenuation of in vivo inflammation and decreased plaque formation in ApoE-deficient mice, supporting an anti-atherogenic role during the progression of atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP922964.RAXCIAbqiPD7hdSOSAYYSWqQ1xca_aWOolwYmeGcnJJsM130_assertion description "[Inhibition of lp-PLA2 by darapladib leads to attenuation of in vivo inflammation and decreased plaque formation in ApoE-deficient mice, supporting an anti-atherogenic role during the progression of atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP922964.RAXCIAbqiPD7hdSOSAYYSWqQ1xca_aWOolwYmeGcnJJsM130_provenance.
- NP786389.RAi0eh2CNqsk5ff0l_ksJmdjVoRuIJf6Yhk_xwmGDfb1Q130_assertion description "[Inhibition of lp-PLA2 by darapladib leads to attenuation of in vivo inflammation and decreased plaque formation in ApoE-deficient mice, supporting an anti-atherogenic role during the progression of atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP786389.RAi0eh2CNqsk5ff0l_ksJmdjVoRuIJf6Yhk_xwmGDfb1Q130_provenance.
- NP922965.RAJnop09vAbLfTML_8f2ct3BPQ5veErMMRkE9RHflMMzg130_assertion description "[Inhibition of lp-PLA2 by darapladib leads to attenuation of in vivo inflammation and decreased plaque formation in ApoE-deficient mice, supporting an anti-atherogenic role during the progression of atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP922965.RAJnop09vAbLfTML_8f2ct3BPQ5veErMMRkE9RHflMMzg130_provenance.